Please ensure Javascript is enabled for purposes of website accessibility

CVS Health to Open Rapid Drive-Through COVID-19 Testing Sites

By Cory Renauer - Apr 6, 2020 at 10:45AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's first two testing locations for the general public, in Georgia and Rhode Island, will be able to deliver results in a matter of minutes.

Some CVS Health (CVS 2.05%) customers are getting a fast new option for COVID-19 testing. Healthcare providers that normally work at the company's retail medical clinics in Georgia and Rhode Island will begin providing drive-up testing in two parking lot pop-ups with results provided while customers wait.

The technology making this new rapid drive-up service possible is Abbott's (ABT 0.90%) ID NOW system. Abbott's machines can amplify and read genetic material quickly enough to provide results for COVID-19 (or a handful of other infections) in minutes.

Blood sample for COVID-19 test.

Image source: Getty Images.

For the safety of its customers and staff, CVS Health will run the rapid-testing services outside its stores. The testers will set up shop in parking lots large enough to accommodate multiple vehicle lanes. Eligible patients will need to register online before showing up at one of CVS Health's pop-up test locations.

Rhode Island Gov. Gina Raimondo said the rapid-testing site CVS Health has planned will double her state's capacity to provide on-the-spot results to thousands daily. Patients will need to meet state residency and age guidelines.

Lessons learned

On March 19, CVS Health opened a parking lot test site in Shrewsbury, Massachusetts, that initially focused on serving first responders and healthcare workers. CVS Health intends to apply lessons learned from that first pop-up molecular diagnostics service center to the new sites in Rhode Island and Georgia.

Rapid testing isn't the first step CVS Health has taken to address the coronavirus pandemic. In recent weeks, the company has also waived charges for home delivery of prescription drugs and dropped the copays for telemedicine visits for those covered by its health insurance service, Aetna.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$106.39 (2.05%) $2.14
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$111.48 (0.90%) $0.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.